Skip to main content
Top
Published in: Current Diabetes Reports 4/2013

01-08-2013 | Microvascular Complications-Neuropathy (D Ziegler, Section Editor)

Painful and Painless Diabetic Neuropathy: One Disease or Two?

Authors: Vincenza Spallone, Carla Greco

Published in: Current Diabetes Reports | Issue 4/2013

Login to get access

Abstract

Painful diabetic polyneuropathy (PDPN) is generally considered a variant of diabetic polyneuropathy (DPN) but the identification of distinctive aspects that characterize painful compared with painless DPN has however been addressed in many studies, mainly with the purpose of better understanding the mechanisms of neuropathic pain in the scenario of peripheral nerve damage of DPN, of determining risk markers for pain development, and also of recognizing who might respond to treatments. This review is aimed at examining available literature dealing with the issue of similarities and differences between painful and painless DPN in an attempt to respond to the question of whether painful and painless DPN are the same disease or not and to address the conundrum of why some people develop the insensate variety of DPN whilst others experience distressing pain. Thus, from the perspective of comparing painful with painless forms of DPN, this review considers the clinical correlates of PDPN, its distinctive framework of symptoms, signs, and nerve functional and structural abnormalities, the question of large and small fiber involvement, the peripheral pain mechanisms, the central processing of pain and some new insights into the pathogenesis of pain in peripheral polyneuropathies and PDPN.
Literature
1.
go back to reference • Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010;33:2285–93. This paper is the summary report of the Toronto consensus meeting on diabetic neuropathy. It provides novel insights into the definition and diagnosis of different forms of diabetic neuropathy.PubMedCrossRef • Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010;33:2285–93. This paper is the summary report of the Toronto consensus meeting on diabetic neuropathy. It provides novel insights into the definition and diagnosis of different forms of diabetic neuropathy.PubMedCrossRef
2.
go back to reference Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW, et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology. 2008;70:1630–5.PubMedCrossRef Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW, et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology. 2008;70:1630–5.PubMedCrossRef
3.
go back to reference Daousi C, MacFarlane IA, Woodward A, Nurmikko TJ, Bundred PE, Benbow SJ. Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes. Diabet Med. 2004;21:976–82.PubMedCrossRef Daousi C, MacFarlane IA, Woodward A, Nurmikko TJ, Bundred PE, Benbow SJ. Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes. Diabet Med. 2004;21:976–82.PubMedCrossRef
4.
go back to reference Davies M, Brophy S, Williams R, Taylor A. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care. 2006;29:1518–22.PubMedCrossRef Davies M, Brophy S, Williams R, Taylor A. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care. 2006;29:1518–22.PubMedCrossRef
5.
go back to reference Ziegler D, Rathmann W, Dickhaus T, Meisinger C, Mielck A, KORA Study Group. Neuropathic pain in diabetes, prediabetes and normal glucose tolerance: the MONICA/KORA Augsburg Surveys S2 and S3. Pain Med. 2009;10:393–400. Ziegler D, Rathmann W, Dickhaus T, Meisinger C, Mielck A, KORA Study Group. Neuropathic pain in diabetes, prediabetes and normal glucose tolerance: the MONICA/KORA Augsburg Surveys S2 and S3. Pain Med. 2009;10:393–400.
6.
go back to reference Van Acker K, Bouhassira D, De Bacquer D, Weiss S, Matthys K, Raemen H, et al. Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics. Diabetes Metab. 2009;35:206–13.PubMedCrossRef Van Acker K, Bouhassira D, De Bacquer D, Weiss S, Matthys K, Raemen H, et al. Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics. Diabetes Metab. 2009;35:206–13.PubMedCrossRef
7.
go back to reference Abbott CA, Malik RA, van Ross ER, Kulkarni J, Boulton AJ. Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K. Diabetes Care. 2011;34:2220–4.PubMedCrossRef Abbott CA, Malik RA, van Ross ER, Kulkarni J, Boulton AJ. Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K. Diabetes Care. 2011;34:2220–4.PubMedCrossRef
8.
go back to reference Miralles-García JM, de Pablos-Velasco P, Cabrerizo L, Pérez M, López-Gómez V, Sociedad Española de Endocrinología y Nutrición. Prevalence of distal diabetic polyneuropathy using quantitative sensory methods in a population with diabetes of more than 10 years’ disease duration. Endocrinol Nutr. 2010;57:414–20. Miralles-García JM, de Pablos-Velasco P, Cabrerizo L, Pérez M, López-Gómez V, Sociedad Española de Endocrinología y Nutrición. Prevalence of distal diabetic polyneuropathy using quantitative sensory methods in a population with diabetes of more than 10 years’ disease duration. Endocrinol Nutr. 2010;57:414–20.
9.
go back to reference Fedele D, Comi G, Coscelli C, Cucinotta D, Feldman EL, Ghirlanda G, et al. A multicenter study on the prevalence of diabetic neuropathy in Italy. Italian Diabetic neuropathy Committee. Diabetes Care. 1997;20:836–43.PubMedCrossRef Fedele D, Comi G, Coscelli C, Cucinotta D, Feldman EL, Ghirlanda G, et al. A multicenter study on the prevalence of diabetic neuropathy in Italy. Italian Diabetic neuropathy Committee. Diabetes Care. 1997;20:836–43.PubMedCrossRef
10.
go back to reference Shaw JE, Zimmet PZ, Gries FA, Ziegler D. Epidemiology of diabetic neuropathy. In: Gries FA, Cameron NE, Low PA, Ziegler D, editors. Textbook of diabetic neuropathy. Stuttgard: Thieme; 2003. p. 64–82. Shaw JE, Zimmet PZ, Gries FA, Ziegler D. Epidemiology of diabetic neuropathy. In: Gries FA, Cameron NE, Low PA, Ziegler D, editors. Textbook of diabetic neuropathy. Stuttgard: Thieme; 2003. p. 64–82.
11.
go back to reference Gore M, Brandenburg NA, Dukes E, Hoffman DL, Tai KS, Stacey B, et al. Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep. J Pain Symptom Manag. 2005;30:374–85.CrossRef Gore M, Brandenburg NA, Dukes E, Hoffman DL, Tai KS, Stacey B, et al. Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep. J Pain Symptom Manag. 2005;30:374–85.CrossRef
12.
go back to reference Tölle T, Xu X, Sadosky AB. Painful diabetic neuropathy: a cross-sectional survey of health state impairment and treatment patterns. J Diabetes Complications. 2006;20:26–33.PubMedCrossRef Tölle T, Xu X, Sadosky AB. Painful diabetic neuropathy: a cross-sectional survey of health state impairment and treatment patterns. J Diabetes Complications. 2006;20:26–33.PubMedCrossRef
13.
go back to reference Fishbain DA, Hall JA, Risser RC, Gonzales JS. Does pain cause the perception of fatigue in patients with chronic pain? Findings from studies for management of diabetic peripheral neuropathic pain with duloxetine. Pain Pract. 2009;9:354–62.PubMedCrossRef Fishbain DA, Hall JA, Risser RC, Gonzales JS. Does pain cause the perception of fatigue in patients with chronic pain? Findings from studies for management of diabetic peripheral neuropathic pain with duloxetine. Pain Pract. 2009;9:354–62.PubMedCrossRef
14.
go back to reference Doth AH, Hansson PT, Jensen MP, Taylor RS. The burden of neuropathic pain: a systematic review and meta-analysis of health utilities. Pain. 2010;149:338–44.PubMedCrossRef Doth AH, Hansson PT, Jensen MP, Taylor RS. The burden of neuropathic pain: a systematic review and meta-analysis of health utilities. Pain. 2010;149:338–44.PubMedCrossRef
15.
go back to reference Turk DC, Audette J, Levy RM, Mackey SC, Stanos S. Assessment and treatment of psychosocial comorbidities in patients with neuropathic pain. Mayo Clin Proc. 2010;85:S42–50.PubMedCrossRef Turk DC, Audette J, Levy RM, Mackey SC, Stanos S. Assessment and treatment of psychosocial comorbidities in patients with neuropathic pain. Mayo Clin Proc. 2010;85:S42–50.PubMedCrossRef
16.
go back to reference Haanpää ML, Gourlay GK, Kent JL, Miaskowski C, Raja SN, Schmader KE, et al. Treatment considerations for patients with neuropathic pain and other medical comorbidities. Mayo Clin Proc. 2010;85:S15–25.PubMedCrossRef Haanpää ML, Gourlay GK, Kent JL, Miaskowski C, Raja SN, Schmader KE, et al. Treatment considerations for patients with neuropathic pain and other medical comorbidities. Mayo Clin Proc. 2010;85:S15–25.PubMedCrossRef
17.
go back to reference Fishbain DA, Cole B, Lewis JE, Gao J. What is the evidence for chronic pain being etiologically associated with the DSM-IV category of sleep disorder due to a general medical condition? A structured evidence-based review. Pain Med. 2010;11:158–79.PubMedCrossRef Fishbain DA, Cole B, Lewis JE, Gao J. What is the evidence for chronic pain being etiologically associated with the DSM-IV category of sleep disorder due to a general medical condition? A structured evidence-based review. Pain Med. 2010;11:158–79.PubMedCrossRef
18.
go back to reference Ritzwoller DP, Ellis JL, Korner EJ, Hartsfield CL, Sadosky A. Comorbidities, healthcare service utilization and costs for patients identified with painful DPN in a managed-care setting. Curr Med Res Opin. 2009;25:1319–28.PubMedCrossRef Ritzwoller DP, Ellis JL, Korner EJ, Hartsfield CL, Sadosky A. Comorbidities, healthcare service utilization and costs for patients identified with painful DPN in a managed-care setting. Curr Med Res Opin. 2009;25:1319–28.PubMedCrossRef
19.
go back to reference DiBonaventura MD, Cappelleri JC, Joshi AV. Association between pain severity and health care resource use, health status, productivity and related costs in painful diabetic peripheral neuropathy patients. Pain Med. 2011;12:799–807.PubMedCrossRef DiBonaventura MD, Cappelleri JC, Joshi AV. Association between pain severity and health care resource use, health status, productivity and related costs in painful diabetic peripheral neuropathy patients. Pain Med. 2011;12:799–807.PubMedCrossRef
20.
go back to reference • Spallone V. Management of painful diabetic neuropathy: guideline guidance or jungle? Curr Diab Rep. 2012;12:403–13. This paper provides a critical evaluation of the guidelines on the management of neuropathic pain.PubMedCrossRef • Spallone V. Management of painful diabetic neuropathy: guideline guidance or jungle? Curr Diab Rep. 2012;12:403–13. This paper provides a critical evaluation of the guidelines on the management of neuropathic pain.PubMedCrossRef
21.
go back to reference Lunn MP, Hughes RA, Wiffen PJ. Duloxetine for treating painful neuropathy or chronic pain. Cochrane Database Syst Rev. 2009;7:CD007115. Lunn MP, Hughes RA, Wiffen PJ. Duloxetine for treating painful neuropathy or chronic pain. Cochrane Database Syst Rev. 2009;7:CD007115.
22.
go back to reference Moore RA, Straube S, Wiffen PJ, Derry S, McQuay HJ. Pregabalin for acute and chronic pain in adults. Cochrane Database Syst Rev. 2009;8:CD007076. Moore RA, Straube S, Wiffen PJ, Derry S, McQuay HJ. Pregabalin for acute and chronic pain in adults. Cochrane Database Syst Rev. 2009;8:CD007076.
23.
go back to reference Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle J, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005;114:29–36.PubMedCrossRef Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle J, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005;114:29–36.PubMedCrossRef
24.
go back to reference • Spallone V, Morganti R, D’Amato C, Greco C, Cacciotti L, Marfia GA. Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy. Diabet Med. 2012;29:578–85. This is the first validation study of the screening tool DN4 for painful diabetic polyneuropathy with values of sensitivity and specificity of 80% and 92%, respectively.PubMedCrossRef • Spallone V, Morganti R, D’Amato C, Greco C, Cacciotti L, Marfia GA. Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy. Diabet Med. 2012;29:578–85. This is the first validation study of the screening tool DN4 for painful diabetic polyneuropathy with values of sensitivity and specificity of 80% and 92%, respectively.PubMedCrossRef
25.
go back to reference Halawa MR, Karawagh A, Zeidan A, Mahmoud AE, Sakr M, Hegazy A. Prevalence of painful diabetic peripheral neuropathy among patients suffering from diabetes mellitus in Saudi Arabia. Curr Med Res Opin. 2010;26:337–43.PubMedCrossRef Halawa MR, Karawagh A, Zeidan A, Mahmoud AE, Sakr M, Hegazy A. Prevalence of painful diabetic peripheral neuropathy among patients suffering from diabetes mellitus in Saudi Arabia. Curr Med Res Opin. 2010;26:337–43.PubMedCrossRef
26.
go back to reference • Jambart S, Ammache Z, Haddad F, Younes A, Hassoun A, Abdalla K, et al. Prevalence of painful diabetic peripheral neuropathy among patients with diabetes mellitus in the Middle East region. J Int Med Res. 2011;39:366–77. This is a large epidemiological study of painful diabetic neuropathy in the Middle East Region.PubMedCrossRef • Jambart S, Ammache Z, Haddad F, Younes A, Hassoun A, Abdalla K, et al. Prevalence of painful diabetic peripheral neuropathy among patients with diabetes mellitus in the Middle East region. J Int Med Res. 2011;39:366–77. This is a large epidemiological study of painful diabetic neuropathy in the Middle East Region.PubMedCrossRef
27.
go back to reference Tesfaye S, Chaturvedi N, Eaton SE, Ward JD, Manes C, Ionescu-Tirgoviste C, et al. Vascular risk factors and diabetic neuropathy.EURODIAB Prospective Complications Study Group. N Engl J Med. 2005;352:341–50.PubMedCrossRef Tesfaye S, Chaturvedi N, Eaton SE, Ward JD, Manes C, Ionescu-Tirgoviste C, et al. Vascular risk factors and diabetic neuropathy.EURODIAB Prospective Complications Study Group. N Engl J Med. 2005;352:341–50.PubMedCrossRef
28.
go back to reference Partanen J, Niskanen L, Lehtinen J, Mervaala E, Siitonen O, Uusitupa M. Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Engl J Med. 1995;13:89–94.CrossRef Partanen J, Niskanen L, Lehtinen J, Mervaala E, Siitonen O, Uusitupa M. Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Engl J Med. 1995;13:89–94.CrossRef
29.
go back to reference Sorensen L, Molyneaux L, Yue DK. Insensate vs painful diabetic neuropathy: the effects of height, gender, ethnicity and glycemic control. Diabetes Res Clin Pract. 2002;57:45–51.PubMedCrossRef Sorensen L, Molyneaux L, Yue DK. Insensate vs painful diabetic neuropathy: the effects of height, gender, ethnicity and glycemic control. Diabetes Res Clin Pract. 2002;57:45–51.PubMedCrossRef
30.
go back to reference Sibal L, Law HN, Gebbie J, Home P. Cardiovascular risk factors predicting the development of distal symmetrical polyneuropathy in people with type 1 diabetes: a 9-year follow-up study. Ann N Y Acad Sci. 2006;1084:304–18.PubMedCrossRef Sibal L, Law HN, Gebbie J, Home P. Cardiovascular risk factors predicting the development of distal symmetrical polyneuropathy in people with type 1 diabetes: a 9-year follow-up study. Ann N Y Acad Sci. 2006;1084:304–18.PubMedCrossRef
31.
go back to reference Ziegler D, Rathmann W, Dickhaus T, Meisinger C, Mielck A, KORA Study Group. Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA/KORA Augsburg Surveys S2 and S3. Diabetes Care. 2008;31:464–9. Ziegler D, Rathmann W, Dickhaus T, Meisinger C, Mielck A, KORA Study Group. Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA/KORA Augsburg Surveys S2 and S3. Diabetes Care. 2008;31:464–9.
32.
go back to reference Ziegler D, Rathmann W, Meisinger C, Dickhaus T, Mielck A, KORA Study Group. Prevalence and risk factors of neuropathic pain in survivors of myocardial infarction with pre-diabetes and diabetes. The KORA Myocardial Infarction Registry. Eur J Pain. 2009;13:582–7. Ziegler D, Rathmann W, Meisinger C, Dickhaus T, Mielck A, KORA Study Group. Prevalence and risk factors of neuropathic pain in survivors of myocardial infarction with pre-diabetes and diabetes. The KORA Myocardial Infarction Registry. Eur J Pain. 2009;13:582–7.
33.
go back to reference Panero F, Novelli G, Zucco C, Fornengo P, Perotto M, Segre O, et al. Fasting plasma C-peptide and micro- and macrovascular complications in a large clinic-based cohort of type 1 diabetic patients. Diabetes Care. 2009;32:301–5.PubMedCrossRef Panero F, Novelli G, Zucco C, Fornengo P, Perotto M, Segre O, et al. Fasting plasma C-peptide and micro- and macrovascular complications in a large clinic-based cohort of type 1 diabetic patients. Diabetes Care. 2009;32:301–5.PubMedCrossRef
34.
go back to reference Pop-Busui R, Roberts L, Pennathur S, Kretzler M, Brosius FC, Feldman EL. The management of diabetic neuropathy in CKD. Am J Kidney Dis. 2010;55:365–85.PubMedCrossRef Pop-Busui R, Roberts L, Pennathur S, Kretzler M, Brosius FC, Feldman EL. The management of diabetic neuropathy in CKD. Am J Kidney Dis. 2010;55:365–85.PubMedCrossRef
35.
go back to reference Davis TM, Yeap BB, Davis WA, Bruce DG. Lipid-lowering therapy and peripheral sensory neuropathy in type 2 diabetes: the Fremantle Diabetes Study. Diabetologia. 2008;51:562–6.PubMedCrossRef Davis TM, Yeap BB, Davis WA, Bruce DG. Lipid-lowering therapy and peripheral sensory neuropathy in type 2 diabetes: the Fremantle Diabetes Study. Diabetologia. 2008;51:562–6.PubMedCrossRef
36.
go back to reference Wiggin TD, Sullivan KA, Pop-Busui R, Amato A, Sima AA, Feldman EL. Elevated triglycerides correlate with progression of diabetic neuropathy. Diabetes. 2009;58:1634–40.PubMedCrossRef Wiggin TD, Sullivan KA, Pop-Busui R, Amato A, Sima AA, Feldman EL. Elevated triglycerides correlate with progression of diabetic neuropathy. Diabetes. 2009;58:1634–40.PubMedCrossRef
37.
go back to reference Sun JK, Keenan HA, Cavallerano JD, Asztalos BF, Schaefer EJ, Sell DR, et al. Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the joslin 50-year medalist study. Diabetes Care. 2011;34:968–74.PubMedCrossRef Sun JK, Keenan HA, Cavallerano JD, Asztalos BF, Schaefer EJ, Sell DR, et al. Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the joslin 50-year medalist study. Diabetes Care. 2011;34:968–74.PubMedCrossRef
38.
go back to reference Harris M, Eastman R, Cowie C. Symptoms of sensory neuropathy in adults with NIDDM in the U.S. population. Diabetes Care. 1993;16:1446–52.PubMedCrossRef Harris M, Eastman R, Cowie C. Symptoms of sensory neuropathy in adults with NIDDM in the U.S. population. Diabetes Care. 1993;16:1446–52.PubMedCrossRef
39.
go back to reference Spallone V, Morganti R, D’Amato C, Cacciotti L, Fedele T, Maiello MR, et al. Clinical correlates of painful diabetic neuropathy and relationship of neuropathic pain with sensorimotor and autonomic nerve function. Eur J Pain. 2011;15:153–60.PubMedCrossRef Spallone V, Morganti R, D’Amato C, Cacciotti L, Fedele T, Maiello MR, et al. Clinical correlates of painful diabetic neuropathy and relationship of neuropathic pain with sensorimotor and autonomic nerve function. Eur J Pain. 2011;15:153–60.PubMedCrossRef
40.
go back to reference Wu EQ, Borton J, Said G, Le TK, Monz B, Rosilio M, et al. Estimated prevalence of peripheral neuropathy and associated pain in adults with diabetes in France. Curr Med Res Opin. 2007;23:2035–42.PubMedCrossRef Wu EQ, Borton J, Said G, Le TK, Monz B, Rosilio M, et al. Estimated prevalence of peripheral neuropathy and associated pain in adults with diabetes in France. Curr Med Res Opin. 2007;23:2035–42.PubMedCrossRef
41.
go back to reference Erbas T, Ertas M, Yucel A, Keskinaslan A, Senocak M, TURNEP Study Group. Prevalence of peripheral neuropathy and painful peripheral neuropathy in Turkish diabetic patients. J Clin Neurophysiol. 2011;28:51–5. Erbas T, Ertas M, Yucel A, Keskinaslan A, Senocak M, TURNEP Study Group. Prevalence of peripheral neuropathy and painful peripheral neuropathy in Turkish diabetic patients. J Clin Neurophysiol. 2011;28:51–5.
42.
go back to reference Benbow SJ, Chan AW, Bowsher D, MacFarlane IA, Williams G. A prospective study of painful symptoms, small-fiber function and peripheral vascular disease in chronic painful diabetic neuropathy. Diabet Med. 1994;11:17–21.PubMedCrossRef Benbow SJ, Chan AW, Bowsher D, MacFarlane IA, Williams G. A prospective study of painful symptoms, small-fiber function and peripheral vascular disease in chronic painful diabetic neuropathy. Diabet Med. 1994;11:17–21.PubMedCrossRef
43.
go back to reference Cheng YJ, Gregg EW, Kahn HS, Williams DE, De Rekeneire N, Narayan KM. Peripheral insensate neuropathy-a tall problem for US adults? Am J Epidemiol. 2006;164:873–80. Cheng YJ, Gregg EW, Kahn HS, Williams DE, De Rekeneire N, Narayan KM. Peripheral insensate neuropathy-a tall problem for US adults? Am J Epidemiol. 2006;164:873–80.
44.
go back to reference Smith AG, Russell J, Feldman EL, Goldstein J, Peltier A, Smith S, et al. Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care. 2006;29:1294–9.PubMedCrossRef Smith AG, Russell J, Feldman EL, Goldstein J, Peltier A, Smith S, et al. Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care. 2006;29:1294–9.PubMedCrossRef
45.
go back to reference Dyck PJ, Klein CJ, Weigand SD. Does impaired glucose metabolism cause polyneuropathy? Review of previous studies and design of a prospective controlled population-based study. Muscle Nerve. 2007;36:536–41.PubMedCrossRef Dyck PJ, Klein CJ, Weigand SD. Does impaired glucose metabolism cause polyneuropathy? Review of previous studies and design of a prospective controlled population-based study. Muscle Nerve. 2007;36:536–41.PubMedCrossRef
46.
go back to reference • Papanas N, Ziegler D. Prediabetic neuropathy: does it exist? Curr Diab Rep. 2012;12:376–83. This paper reviews available findings on epidemiological, clinical, and pathogenetic aspects of peripheral and autonomic prediabetic neuropathy.PubMedCrossRef • Papanas N, Ziegler D. Prediabetic neuropathy: does it exist? Curr Diab Rep. 2012;12:376–83. This paper reviews available findings on epidemiological, clinical, and pathogenetic aspects of peripheral and autonomic prediabetic neuropathy.PubMedCrossRef
47.
go back to reference Herman RM, Brower JB, Stoddard DG, Casano AR, Targovnik JH, Herman JH, et al. Prevalence of somatic small fiber neuropathy in obesity. Int J Obes. 2007;31:226–35.CrossRef Herman RM, Brower JB, Stoddard DG, Casano AR, Targovnik JH, Herman JH, et al. Prevalence of somatic small fiber neuropathy in obesity. Int J Obes. 2007;31:226–35.CrossRef
48.
go back to reference Smith AG, Rose K, Singleton JR. Idiopathic neuropathy patients are at high risk for metabolic syndrome. J Neurol Sci. 2008;273:25–8.PubMedCrossRef Smith AG, Rose K, Singleton JR. Idiopathic neuropathy patients are at high risk for metabolic syndrome. J Neurol Sci. 2008;273:25–8.PubMedCrossRef
49.
go back to reference Figueroa-Romero C, Sadidi M, Feldman EL. Mechanisms of disease: the oxidative stress theory of diabetic neuropathy. Rev Endocr Metab Disord. 2008;9:301–14.PubMedCrossRef Figueroa-Romero C, Sadidi M, Feldman EL. Mechanisms of disease: the oxidative stress theory of diabetic neuropathy. Rev Endocr Metab Disord. 2008;9:301–14.PubMedCrossRef
50.
go back to reference Cameron NE, Cotter MA. Pro-inflammatory mechanisms in diabetic neuropathy: focus on the nuclear factor kappa B pathway. Curr Drug Targets. 2008;9:60–7.PubMedCrossRef Cameron NE, Cotter MA. Pro-inflammatory mechanisms in diabetic neuropathy: focus on the nuclear factor kappa B pathway. Curr Drug Targets. 2008;9:60–7.PubMedCrossRef
51.
go back to reference Maury E, Brichard SM. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol. 2010;314:1–16.PubMedCrossRef Maury E, Brichard SM. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol. 2010;314:1–16.PubMedCrossRef
52.
go back to reference Ohayon MM, Stingl JC. Prevalence and comorbidity of chronic pain in the German general population. J Psychiatr Res. 2012;46:444–50.PubMedCrossRef Ohayon MM, Stingl JC. Prevalence and comorbidity of chronic pain in the German general population. J Psychiatr Res. 2012;46:444–50.PubMedCrossRef
53.
go back to reference Yagihashi S, Yamagishi S, Wada R. Pathology and pathogenetic mechanisms of diabetic neuropathy: correlation with clinical signs and symptoms. Diabetes Res Clin Pract. 2007;77:S184–9.PubMedCrossRef Yagihashi S, Yamagishi S, Wada R. Pathology and pathogenetic mechanisms of diabetic neuropathy: correlation with clinical signs and symptoms. Diabetes Res Clin Pract. 2007;77:S184–9.PubMedCrossRef
54.
go back to reference Boulton AJM, Armstrong WD, Scarpello JHB, Ward JD. The natural history of painful diabetic neuropathy: a 4-year study. Postgr Med J. 1983;59:556–9.CrossRef Boulton AJM, Armstrong WD, Scarpello JHB, Ward JD. The natural history of painful diabetic neuropathy: a 4-year study. Postgr Med J. 1983;59:556–9.CrossRef
55.
go back to reference Galer BS, Gianas A, Jensen MP. Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Res Clin Pract. 2000;47:123–8.PubMedCrossRef Galer BS, Gianas A, Jensen MP. Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Res Clin Pract. 2000;47:123–8.PubMedCrossRef
56.
go back to reference Veves A, Manes C, Murray HJ, Young MJ, Boulton AJ. Painful neuropathy and foot ulceration in diabetic patients. Diabetes Care. 1993;16:1187–9.PubMedCrossRef Veves A, Manes C, Murray HJ, Young MJ, Boulton AJ. Painful neuropathy and foot ulceration in diabetic patients. Diabetes Care. 1993;16:1187–9.PubMedCrossRef
58.
go back to reference Veves A, Young MJ, Manes C, Boulton AJ. Differences in peripheral and autonomic nerve function measurements in painful and painless neuropathy. A clinical study. Diabetes Care. 1994;17:1200–2.PubMedCrossRef Veves A, Young MJ, Manes C, Boulton AJ. Differences in peripheral and autonomic nerve function measurements in painful and painless neuropathy. A clinical study. Diabetes Care. 1994;17:1200–2.PubMedCrossRef
59.
go back to reference Mondelli M, Aretini A, Baldasseroni A. Distal symmetric polyneuropathy in diabetes. Differences between patients with and without neuropathic pain. Exp Clin Endocrinol Diabetes. 2012;120:45–50.PubMedCrossRef Mondelli M, Aretini A, Baldasseroni A. Distal symmetric polyneuropathy in diabetes. Differences between patients with and without neuropathic pain. Exp Clin Endocrinol Diabetes. 2012;120:45–50.PubMedCrossRef
60.
go back to reference Krumova EK, Geber C, Westermann A, Maier C. Neuropathic pain: is quantitative sensory testing helpful? Curr Diab Rep. 2012;12:393–402.PubMedCrossRef Krumova EK, Geber C, Westermann A, Maier C. Neuropathic pain: is quantitative sensory testing helpful? Curr Diab Rep. 2012;12:393–402.PubMedCrossRef
61.
go back to reference Tsigos C, White A, Young RJ. Discrimination between painful and painless diabetic neuropathy based on testing of large somatic nerve and sympathetic nerve function. Diabet Med. 1992;9:359–65.PubMedCrossRef Tsigos C, White A, Young RJ. Discrimination between painful and painless diabetic neuropathy based on testing of large somatic nerve and sympathetic nerve function. Diabet Med. 1992;9:359–65.PubMedCrossRef
62.
go back to reference Krämer HH, Rolke R, Bickel A, Birklein F. Thermal thresholds predict painfulness of diabetic neuropathies. Diabetes Care. 2004;27:2386–91.PubMedCrossRef Krämer HH, Rolke R, Bickel A, Birklein F. Thermal thresholds predict painfulness of diabetic neuropathies. Diabetes Care. 2004;27:2386–91.PubMedCrossRef
63.
go back to reference Vrethem M, Boivie J, Arnqvist H, Holmgren H, Lindström T. Painful polyneuropathy in patients with and without diabetes: clinical, neurophysiologic, and quantitative sensory characteristics. Clin J Pain. 2002;18:122–7.PubMedCrossRef Vrethem M, Boivie J, Arnqvist H, Holmgren H, Lindström T. Painful polyneuropathy in patients with and without diabetes: clinical, neurophysiologic, and quantitative sensory characteristics. Clin J Pain. 2002;18:122–7.PubMedCrossRef
64.
go back to reference • Lauria G, Lombardi R. Small fiber neuropathy: is skin biopsy the holy grail? Curr Diab Rep. 2012;12:384–92. This paper is a comprehensive review on contemporary issues in small fiber neuropathy.PubMedCrossRef • Lauria G, Lombardi R. Small fiber neuropathy: is skin biopsy the holy grail? Curr Diab Rep. 2012;12:384–92. This paper is a comprehensive review on contemporary issues in small fiber neuropathy.PubMedCrossRef
65.
go back to reference Sorensen L, Molyneaux L, Yue DK. The relationship among pain, sensory loss, and small nerve fibers in diabetes. Diabetes Care. 2006;29:883–7.PubMedCrossRef Sorensen L, Molyneaux L, Yue DK. The relationship among pain, sensory loss, and small nerve fibers in diabetes. Diabetes Care. 2006;29:883–7.PubMedCrossRef
66.
go back to reference Quattrini C, Tavakoli M, Jeziorska M, Kallinikos P, Tesfaye S, Finnigan J, et al. Surrogate markers of small fiber damage in human diabetic neuropathy. Diabetes. 2007;56:2148–54.PubMedCrossRef Quattrini C, Tavakoli M, Jeziorska M, Kallinikos P, Tesfaye S, Finnigan J, et al. Surrogate markers of small fiber damage in human diabetic neuropathy. Diabetes. 2007;56:2148–54.PubMedCrossRef
67.
go back to reference Devigili G, Tugnoli V, Penza P, Camozzi F, Lombardi R, Melli G, et al. The diagnostic criteria for small fiber neuropathy: from symptoms to neuropathology. Brain. 2008;131:1912–25.PubMedCrossRef Devigili G, Tugnoli V, Penza P, Camozzi F, Lombardi R, Melli G, et al. The diagnostic criteria for small fiber neuropathy: from symptoms to neuropathology. Brain. 2008;131:1912–25.PubMedCrossRef
68.
go back to reference Scherens A, Maier C, Haussleiter IS, Schwenkreis P, Vlckova-Moravcova E, Baron R, et al. Painful or painless lower limb dysesthesias are highly predictive of peripheral neuropathy: comparison of different diagnostic modalities. Eur J Pain. 2009;13:711–8.PubMedCrossRef Scherens A, Maier C, Haussleiter IS, Schwenkreis P, Vlckova-Moravcova E, Baron R, et al. Painful or painless lower limb dysesthesias are highly predictive of peripheral neuropathy: comparison of different diagnostic modalities. Eur J Pain. 2009;13:711–8.PubMedCrossRef
69.
go back to reference Said G, Slama G, Selva J. Progressive centripetal degeneration of axons in small fiber diabetic polyneuropathy. Brain. 1983;106:791–807.PubMedCrossRef Said G, Slama G, Selva J. Progressive centripetal degeneration of axons in small fiber diabetic polyneuropathy. Brain. 1983;106:791–807.PubMedCrossRef
70.
go back to reference Winkler AS, Ejskjaer N, Edmonds M, Watkins PJ. Dissociated sensory loss in diabetic autonomic neuropathy. Diabet Med. 2000;17:457–62.PubMedCrossRef Winkler AS, Ejskjaer N, Edmonds M, Watkins PJ. Dissociated sensory loss in diabetic autonomic neuropathy. Diabet Med. 2000;17:457–62.PubMedCrossRef
71.
go back to reference Jimenez-Cohl P, Grekin C, Leyton C, Vargas C, Villaseca R. Thermal threshold: research study on small fiber dysfunction in distal diabetic polyneuropathy. J Diabetes Sci Technol. 2012;6:177–83. Jimenez-Cohl P, Grekin C, Leyton C, Vargas C, Villaseca R. Thermal threshold: research study on small fiber dysfunction in distal diabetic polyneuropathy. J Diabetes Sci Technol. 2012;6:177–83.
72.
go back to reference Ziegler D, Mayer P, Gries FA. Evaluation of thermal, pain, and vibration sensation thresholds in newly diagnosed type 1 diabetic patients. J Neurol Neurosurg Psychiatry. 1988;51:1420–4.PubMedCrossRef Ziegler D, Mayer P, Gries FA. Evaluation of thermal, pain, and vibration sensation thresholds in newly diagnosed type 1 diabetic patients. J Neurol Neurosurg Psychiatry. 1988;51:1420–4.PubMedCrossRef
73.
go back to reference Dyck PJ, Dyck PJ, Larson TS, O’Brien PC, Velosa JA. Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: a study of 3 cohorts. Diabetes Care. 2000;23:510–7.PubMedCrossRef Dyck PJ, Dyck PJ, Larson TS, O’Brien PC, Velosa JA. Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: a study of 3 cohorts. Diabetes Care. 2000;23:510–7.PubMedCrossRef
74.
go back to reference Zinman LH, Bril V, Perkins BA. Cooling detection thresholds in the assessment of diabetic sensory polyneuropathy: comparison of CASE IV and Medoc instruments. Diabetes Care. 2004;27:1674–9.PubMedCrossRef Zinman LH, Bril V, Perkins BA. Cooling detection thresholds in the assessment of diabetic sensory polyneuropathy: comparison of CASE IV and Medoc instruments. Diabetes Care. 2004;27:1674–9.PubMedCrossRef
75.
go back to reference Vlckova-Moravcova E, Bednarik J, Belobradkova J, Sommer C. Small-fiber involvement in diabetic patients with neuropathic foot pain. Diabet Med. 2008;25:692–9.PubMedCrossRef Vlckova-Moravcova E, Bednarik J, Belobradkova J, Sommer C. Small-fiber involvement in diabetic patients with neuropathic foot pain. Diabet Med. 2008;25:692–9.PubMedCrossRef
76.
go back to reference Umapathi T, Tan WL, Loke SC, Soon PC, Tavintharan S, Chan YH. Intraepidermal nerve fiber density as a marker of early diabetic neuropathy. Muscle Nerve. 2007;35:591–8.PubMedCrossRef Umapathi T, Tan WL, Loke SC, Soon PC, Tavintharan S, Chan YH. Intraepidermal nerve fiber density as a marker of early diabetic neuropathy. Muscle Nerve. 2007;35:591–8.PubMedCrossRef
77.
go back to reference Ragé M, Van Acker N, Knaapen MW, Timmers M, Streffer J, Hermans MP, et al. Asymptomatic small fiber neuropathy in diabetes mellitus: investigations with intraepidermal nerve fiber density, quantitative sensory testing and laser-evoked potentials. J Neurol. 2011;258:1852–64.PubMedCrossRef Ragé M, Van Acker N, Knaapen MW, Timmers M, Streffer J, Hermans MP, et al. Asymptomatic small fiber neuropathy in diabetes mellitus: investigations with intraepidermal nerve fiber density, quantitative sensory testing and laser-evoked potentials. J Neurol. 2011;258:1852–64.PubMedCrossRef
78.
go back to reference Løseth S, Mellgren SI, Jorde R, Lindal S, Stålberg E. Polyneuropathy in type and type 2 diabetes: comparison of nerve conduction studies, thermal perception thresholds and intraepidermal nerve fiber densities. Diabetes Metab Res Rev. 2010;26:100–6.PubMedCrossRef Løseth S, Mellgren SI, Jorde R, Lindal S, Stålberg E. Polyneuropathy in type and type 2 diabetes: comparison of nerve conduction studies, thermal perception thresholds and intraepidermal nerve fiber densities. Diabetes Metab Res Rev. 2010;26:100–6.PubMedCrossRef
79.
go back to reference Putz Z, Tabák AG, Tóth N, Istenes I, Németh N, Gandhi RA, et al. Noninvasive evaluation of neural impairment in subjects with impaired glucose tolerance. Diabetes Care. 2009;32:181–3.PubMedCrossRef Putz Z, Tabák AG, Tóth N, Istenes I, Németh N, Gandhi RA, et al. Noninvasive evaluation of neural impairment in subjects with impaired glucose tolerance. Diabetes Care. 2009;32:181–3.PubMedCrossRef
80.
go back to reference Bickel A, Butz M, Schmelz M, Handwerker HO, Neundörfer B. Density of sympathetic axons in sural nerve biopsies of neuropathy patients is related to painfulness. Pain. 2000;84:413–9.PubMedCrossRef Bickel A, Butz M, Schmelz M, Handwerker HO, Neundörfer B. Density of sympathetic axons in sural nerve biopsies of neuropathy patients is related to painfulness. Pain. 2000;84:413–9.PubMedCrossRef
81.
go back to reference Tack CJ, van Gurp PJ, Holmes C, Goldstein DS. Local sympathetic denervation in painful diabetic neuropathy. Diabetes. 2002;51:3545–53.PubMedCrossRef Tack CJ, van Gurp PJ, Holmes C, Goldstein DS. Local sympathetic denervation in painful diabetic neuropathy. Diabetes. 2002;51:3545–53.PubMedCrossRef
82.
go back to reference • Gibbons CH, Freeman R. Treatment-induced diabetic neuropathy: a reversible painful autonomic neuropathy. Ann Neurol. 2010;67:534–41. The largest case series and first detailed analysis of acute neuropathies associated with glycemic control.PubMedCrossRef • Gibbons CH, Freeman R. Treatment-induced diabetic neuropathy: a reversible painful autonomic neuropathy. Ann Neurol. 2010;67:534–41. The largest case series and first detailed analysis of acute neuropathies associated with glycemic control.PubMedCrossRef
83.
go back to reference Novak V, Freimer ML, Kissel JT, Sahenk Z, Periquet IM, Nash SM, et al. Autonomic impairment in painful neuropathy. Neurology. 2001;56:861–8.PubMedCrossRef Novak V, Freimer ML, Kissel JT, Sahenk Z, Periquet IM, Nash SM, et al. Autonomic impairment in painful neuropathy. Neurology. 2001;56:861–8.PubMedCrossRef
84.
go back to reference Singer W, Spies JM, McArthur J, et al. Prospective evaluation of somatic and autonomic small fibers in selected autonomic neuropathies. Neurology. 2004;62:612–8.PubMedCrossRef Singer W, Spies JM, McArthur J, et al. Prospective evaluation of somatic and autonomic small fibers in selected autonomic neuropathies. Neurology. 2004;62:612–8.PubMedCrossRef
85.
go back to reference Young RJ, Zhou YQ, Rodriguez E, Prescott RJ, Ewing DJ, Clarke BF. Variable relationship between peripheral somatic and autonomic neuropathy in patients with different syndromes of diabetic polyneuropathy. Diabetes. 1986;35:192–7.PubMedCrossRef Young RJ, Zhou YQ, Rodriguez E, Prescott RJ, Ewing DJ, Clarke BF. Variable relationship between peripheral somatic and autonomic neuropathy in patients with different syndromes of diabetic polyneuropathy. Diabetes. 1986;35:192–7.PubMedCrossRef
86.
go back to reference Gandhi RA, Marques JL, Selvarajah D, Emery CJ, Tesfaye S. Painful diabetic neuropathy is associated with greater autonomic dysfunction than painless diabetic neuropathy. Diabetes Care. 2010;33:1585–90.PubMedCrossRef Gandhi RA, Marques JL, Selvarajah D, Emery CJ, Tesfaye S. Painful diabetic neuropathy is associated with greater autonomic dysfunction than painless diabetic neuropathy. Diabetes Care. 2010;33:1585–90.PubMedCrossRef
87.
go back to reference Chouchou F, Pichot V, Perchet C, Legrain V, Garcia-Larrea L, Roche F, et al. Autonomic pain responses during sleep: a study of heart rate variability. Eur J Pain. 2011;15:554–60.PubMedCrossRef Chouchou F, Pichot V, Perchet C, Legrain V, Garcia-Larrea L, Roche F, et al. Autonomic pain responses during sleep: a study of heart rate variability. Eur J Pain. 2011;15:554–60.PubMedCrossRef
88.
go back to reference Spallone V, Morganti R, D’Amato C, Di Gennaro F, Greco C, Cacciotti L, et al. Nondipping is a novel associated disorder of painful diabetic polyneuropathy. Diabetologia. 2012;55:S480. Spallone V, Morganti R, D’Amato C, Di Gennaro F, Greco C, Cacciotti L, et al. Nondipping is a novel associated disorder of painful diabetic polyneuropathy. Diabetologia. 2012;55:S480.
89.
go back to reference Storella RJ, Shi Y, O’Connor DM, Pharo GH, Abrams JT, Levitt J. Relief of chronic pain may be accompanied by an increase in a measure of heart rate variability. Anesth Analg. 1999;89:448–50.PubMed Storella RJ, Shi Y, O’Connor DM, Pharo GH, Abrams JT, Levitt J. Relief of chronic pain may be accompanied by an increase in a measure of heart rate variability. Anesth Analg. 1999;89:448–50.PubMed
90.
go back to reference Bouhassira D, Attal N, Willer JC, Brasseur L. Painful and painless peripheral sensory neuropathies due to HIV infection: a comparison using quantitative sensory evaluation. Pain. 1999;80:265–72.PubMedCrossRef Bouhassira D, Attal N, Willer JC, Brasseur L. Painful and painless peripheral sensory neuropathies due to HIV infection: a comparison using quantitative sensory evaluation. Pain. 1999;80:265–72.PubMedCrossRef
91.
go back to reference Britland ST, Young RJ, Sharma AK, Clarke BF. Acute and remitting painful diabetic polyneuropathy: a comparison of peripheral nerve fiber pathology. Pain. 1992;48:361–70.PubMedCrossRef Britland ST, Young RJ, Sharma AK, Clarke BF. Acute and remitting painful diabetic polyneuropathy: a comparison of peripheral nerve fiber pathology. Pain. 1992;48:361–70.PubMedCrossRef
92.
go back to reference Thomas PK. Diabetic sensorimotor neuropathy: treatment. In: Gries FA, Cameron NE, Low PA, Ziegler D, editors. Textbook of diabetic neuropathy. Stuttgard: Thieme; 2003. p. 208–11. Thomas PK. Diabetic sensorimotor neuropathy: treatment. In: Gries FA, Cameron NE, Low PA, Ziegler D, editors. Textbook of diabetic neuropathy. Stuttgard: Thieme; 2003. p. 208–11.
93.
go back to reference Llewelyn JG, Gilbey SG, Thomas PK, King RH, Muddle JR, Watkins PJ. Sural nerve morphometry in diabetic autonomic and painful sensory neuropathy: a clinico pathological study. Brain. 1991;114:867–92.PubMedCrossRef Llewelyn JG, Gilbey SG, Thomas PK, King RH, Muddle JR, Watkins PJ. Sural nerve morphometry in diabetic autonomic and painful sensory neuropathy: a clinico pathological study. Brain. 1991;114:867–92.PubMedCrossRef
94.
go back to reference Malik RA, Veves A, Walker D, Siddique I, Lye RH, Schady W, et al. Sural nerve fiber pathology in diabetic patients with mild neuropathy: relationship to pain, quantitative sensory testing and peripheral nerve electrophysiology. Acta Neuropathol. 2001;101:367–74.PubMed Malik RA, Veves A, Walker D, Siddique I, Lye RH, Schady W, et al. Sural nerve fiber pathology in diabetic patients with mild neuropathy: relationship to pain, quantitative sensory testing and peripheral nerve electrophysiology. Acta Neuropathol. 2001;101:367–74.PubMed
95.
go back to reference Tavakoli M, Petropoulos IN, Malik RA. Assessing corneal nerve structure and function in diabetic neuropathy. Clin Exp Optom. 2012;95:338–47.PubMedCrossRef Tavakoli M, Petropoulos IN, Malik RA. Assessing corneal nerve structure and function in diabetic neuropathy. Clin Exp Optom. 2012;95:338–47.PubMedCrossRef
96.
go back to reference Archer AG, Roberts VC, Watkins PJ. Blood flow patterns in painful diabetic neuropathy. Diabetologia. 1984;27:563–7.PubMedCrossRef Archer AG, Roberts VC, Watkins PJ. Blood flow patterns in painful diabetic neuropathy. Diabetologia. 1984;27:563–7.PubMedCrossRef
97.
go back to reference Eaton SE, Harris ND, Ibrahim S, Patel KA, Selmi F, Radatz M, et al. Increased sural nerve epineurial blood flow in human subjects with painful diabetic neuropathy. Diabetologia. 2003;46:934–9.PubMedCrossRef Eaton SE, Harris ND, Ibrahim S, Patel KA, Selmi F, Radatz M, et al. Increased sural nerve epineurial blood flow in human subjects with painful diabetic neuropathy. Diabetologia. 2003;46:934–9.PubMedCrossRef
98.
go back to reference Malik RA, Tesfaye S, Newrick PG, Walker D, Rajbhandari SM, Siddique I, et al. Sural nerve pathology in diabetic patients with minimal but progressive neuropathy. Diabetologia. 2005;48:578–85.PubMedCrossRef Malik RA, Tesfaye S, Newrick PG, Walker D, Rajbhandari SM, Siddique I, et al. Sural nerve pathology in diabetic patients with minimal but progressive neuropathy. Diabetologia. 2005;48:578–85.PubMedCrossRef
99.
go back to reference Tesfaye S, Selvarajah D. Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy. Diabetes Metab Res Rev. 2012;1:8–14.CrossRef Tesfaye S, Selvarajah D. Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy. Diabetes Metab Res Rev. 2012;1:8–14.CrossRef
100.
go back to reference Quattrini C, Harris ND, Malik RA, Tesfaye S. Impaired skin microvascular reactivity in painful diabetic neuropathy. Diabetes Care. 2007;30:655–9.PubMedCrossRef Quattrini C, Harris ND, Malik RA, Tesfaye S. Impaired skin microvascular reactivity in painful diabetic neuropathy. Diabetes Care. 2007;30:655–9.PubMedCrossRef
101.
go back to reference Doupis J, Lyons TE, Wu S, Dinh T, Veves A. Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathy. J Clin Endocrinol Metab. 2009;94:2157–63.PubMedCrossRef Doupis J, Lyons TE, Wu S, Dinh T, Veves A. Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathy. J Clin Endocrinol Metab. 2009;94:2157–63.PubMedCrossRef
102.
go back to reference Yuen KC, Baker NR, Rayman G. Treatment of chronic painful diabetic neuropathy with isosorbide dinitrate spray: a double-blind placebo-controlled cross-over study. Diabetes Care. 2002;25:1699–703.PubMedCrossRef Yuen KC, Baker NR, Rayman G. Treatment of chronic painful diabetic neuropathy with isosorbide dinitrate spray: a double-blind placebo-controlled cross-over study. Diabetes Care. 2002;25:1699–703.PubMedCrossRef
103.
go back to reference Rayman G, Baker NR, Krishnan ST. Glyceryl trinitrate patches as an alternative to isosorbide dinitrate spray in the treatment of chronic painful diabetic neuropathy. Diabetes Care. 2003;26:2697–8.PubMedCrossRef Rayman G, Baker NR, Krishnan ST. Glyceryl trinitrate patches as an alternative to isosorbide dinitrate spray in the treatment of chronic painful diabetic neuropathy. Diabetes Care. 2003;26:2697–8.PubMedCrossRef
104.
go back to reference Costigan M, Scholz J, Woolf CJ. Neuropathic pain: a maladaptive response of the nervous system to damage. Annu Rev Neurosci. 2009;32:1–32.PubMedCrossRef Costigan M, Scholz J, Woolf CJ. Neuropathic pain: a maladaptive response of the nervous system to damage. Annu Rev Neurosci. 2009;32:1–32.PubMedCrossRef
105.
go back to reference • Baron R, Binder A, Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol. 2010;9:807–19. This is a practical review on pathophysiology, diagnosis, sensory profile, and treatment of neuropathic pain.PubMedCrossRef • Baron R, Binder A, Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol. 2010;9:807–19. This is a practical review on pathophysiology, diagnosis, sensory profile, and treatment of neuropathic pain.PubMedCrossRef
106.
go back to reference • Berger JV, Knaepen L, Janssen SP, Jaken RJ, Marcus MA, Joosten EA, et al. Cellular and molecular insights into neuropathy-induced pain hypersensitivity for mechanism-based treatment approaches. Brain Res Rev. 2011;67:282–310. This is an updated complete review of novel experimental treatment approaches to neuropathic pain, mainly acting on the spinal nociceptive network.PubMedCrossRef • Berger JV, Knaepen L, Janssen SP, Jaken RJ, Marcus MA, Joosten EA, et al. Cellular and molecular insights into neuropathy-induced pain hypersensitivity for mechanism-based treatment approaches. Brain Res Rev. 2011;67:282–310. This is an updated complete review of novel experimental treatment approaches to neuropathic pain, mainly acting on the spinal nociceptive network.PubMedCrossRef
107.
go back to reference Ochoa JL, Campero M, Serra J, Bostock H. Hyperexcitable polymodal and insensitive nociceptors in painful human neuropathy. Muscle Nerve. 2005;32:459–72.PubMedCrossRef Ochoa JL, Campero M, Serra J, Bostock H. Hyperexcitable polymodal and insensitive nociceptors in painful human neuropathy. Muscle Nerve. 2005;32:459–72.PubMedCrossRef
108.
go back to reference Ørstavik K, Namer B, Schmidt R, Schmelz M, Hilliges M, Weidner C, et al. Abnormal function of C-fibers in patients with diabetic neuropathy. J Neurosci. 2006;26:11287–94.PubMedCrossRef Ørstavik K, Namer B, Schmidt R, Schmelz M, Hilliges M, Weidner C, et al. Abnormal function of C-fibers in patients with diabetic neuropathy. J Neurosci. 2006;26:11287–94.PubMedCrossRef
109.
go back to reference Serra J, Bostock H, Solà R, Aleu J, García E, Cokic B, et al. Microneurographic identification of spontaneous activity in C-nociceptors in neuropathic pain states in humans and rats. Pain. 2012;153:42–55.PubMedCrossRef Serra J, Bostock H, Solà R, Aleu J, García E, Cokic B, et al. Microneurographic identification of spontaneous activity in C-nociceptors in neuropathic pain states in humans and rats. Pain. 2012;153:42–55.PubMedCrossRef
110.
go back to reference Baron R, Tölle TR, Gockel U, Brosz M, Freynhagen R. A cross-sectional cohort survey in 2100 patients with painful diabetic neuropathy and postherpetic neuralgia: differences in demographic data and sensory symptoms. Pain. 2009;146:34–40.PubMedCrossRef Baron R, Tölle TR, Gockel U, Brosz M, Freynhagen R. A cross-sectional cohort survey in 2100 patients with painful diabetic neuropathy and postherpetic neuralgia: differences in demographic data and sensory symptoms. Pain. 2009;146:34–40.PubMedCrossRef
111.
go back to reference Spallone V, Morganti R, Greco C, D’ Amato C, Cacciotti L, Marfia GA. Sensory profiles of neuropathic pain in painful diabetic polyneuropathy. Diabetologia. 2011;54:S460. Spallone V, Morganti R, Greco C, D’ Amato C, Cacciotti L, Marfia GA. Sensory profiles of neuropathic pain in painful diabetic polyneuropathy. Diabetologia. 2011;54:S460.
112.
go back to reference Cruccu G, Truini A. Sensory profiles: a new strategy for selecting patients in treatment trials for neuropathic pain. Pain. 2009;146:5–6.PubMedCrossRef Cruccu G, Truini A. Sensory profiles: a new strategy for selecting patients in treatment trials for neuropathic pain. Pain. 2009;146:5–6.PubMedCrossRef
113.
go back to reference Truini A, Biasiotta A, La Cesa S, Di Stefano G, Galeotti F, Petrucci MT, et al. Mechanisms of pain in distal symmetric polyneuropathy: a combined clinical and neurophysiological study. Pain. 2010;150:516–21.PubMedCrossRef Truini A, Biasiotta A, La Cesa S, Di Stefano G, Galeotti F, Petrucci MT, et al. Mechanisms of pain in distal symmetric polyneuropathy: a combined clinical and neurophysiological study. Pain. 2010;150:516–21.PubMedCrossRef
114.
go back to reference Herder C, Lankisch M, Ziegler D, Rathmann W, Koenig W, Illig T, et al. Subclinical inflammation and diabetic polyneuropathy: MONICA/KORA Survey F3 (Augsburg, Germany). Diabetes Care. 2009;32:680–2.PubMedCrossRef Herder C, Lankisch M, Ziegler D, Rathmann W, Koenig W, Illig T, et al. Subclinical inflammation and diabetic polyneuropathy: MONICA/KORA Survey F3 (Augsburg, Germany). Diabetes Care. 2009;32:680–2.PubMedCrossRef
115.
go back to reference Myers RR, Campana WM, Shubayev VI. The role of neuroinflammation in neuropathic pain: mechanisms and therapeutic targets. Drug Discov Today. 2006;11:8–20.PubMedCrossRef Myers RR, Campana WM, Shubayev VI. The role of neuroinflammation in neuropathic pain: mechanisms and therapeutic targets. Drug Discov Today. 2006;11:8–20.PubMedCrossRef
116.
go back to reference • Calvo M, Dawes JM, Bennett DL. The role of the immune system in the generation of neuropathic pain. Lancet Neurol. 2012;11:629–42. This is an interesting review on the experimental and human studies showing a bi-directional signalling between sensory and the immune system in the neuropathic pain generation and maintenance.PubMedCrossRef • Calvo M, Dawes JM, Bennett DL. The role of the immune system in the generation of neuropathic pain. Lancet Neurol. 2012;11:629–42. This is an interesting review on the experimental and human studies showing a bi-directional signalling between sensory and the immune system in the neuropathic pain generation and maintenance.PubMedCrossRef
117.
go back to reference Uçeyler N, Rogausch JP, Toyka KV, Sommer C. Differential expression of cytokines in painful and painless neuropathies. Neurology. 2007;69:42–9.PubMedCrossRef Uçeyler N, Rogausch JP, Toyka KV, Sommer C. Differential expression of cytokines in painful and painless neuropathies. Neurology. 2007;69:42–9.PubMedCrossRef
118.
go back to reference Purwata TE. High TNF-alpha plasma levels and macrophages iNOS and TNF-alpha expression as risk factors for painful diabetic neuropathy. J Pain Res. 2011;4:169–75.PubMedCrossRef Purwata TE. High TNF-alpha plasma levels and macrophages iNOS and TNF-alpha expression as risk factors for painful diabetic neuropathy. J Pain Res. 2011;4:169–75.PubMedCrossRef
119.
go back to reference Obrosova IG. Diabetic painful and insensate neuropathy: pathogenesis and potential treatments. Neurotherapeutics. 2009;6:638–47.PubMedCrossRef Obrosova IG. Diabetic painful and insensate neuropathy: pathogenesis and potential treatments. Neurotherapeutics. 2009;6:638–47.PubMedCrossRef
120.
go back to reference Fernyhough P, Calcutt NA. Abnormal calcium homeostasis in peripheral neuropathies. Cell Calcium. 2010;47:130–9.PubMedCrossRef Fernyhough P, Calcutt NA. Abnormal calcium homeostasis in peripheral neuropathies. Cell Calcium. 2010;47:130–9.PubMedCrossRef
121.
go back to reference Stirban A, Tschoepe D, Stratmann B. Shifting the disease management paradigm from glucose: what are the pros? Diabetes Care. 2009;32 Suppl 2:S349–52.PubMedCrossRef Stirban A, Tschoepe D, Stratmann B. Shifting the disease management paradigm from glucose: what are the pros? Diabetes Care. 2009;32 Suppl 2:S349–52.PubMedCrossRef
122.
go back to reference •• Bierhaus A, Fleming T, Stoyanov S, Leffler A, Babes A, Neacsu C, et al. Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy. Nat Med. 2012;18:926–33. This study shows a mechanism for hyperalgesia based on the glycolytic metabolite methylglyoxal. It introduces a previously undescribed pain mechanism and supports a concept of metabolically driven hyperalgesia in diabetes.PubMedCrossRef •• Bierhaus A, Fleming T, Stoyanov S, Leffler A, Babes A, Neacsu C, et al. Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy. Nat Med. 2012;18:926–33. This study shows a mechanism for hyperalgesia based on the glycolytic metabolite methylglyoxal. It introduces a previously undescribed pain mechanism and supports a concept of metabolically driven hyperalgesia in diabetes.PubMedCrossRef
123.
go back to reference Skapare E, Konrade I, Liepinsh E, Makrecka M, Zvejniece L, Svalbe B, et al. Glyoxalase 1 and glyoxalase 2 activities in blood and neuronal tissue samples from experimental animal models of obesity and type 2 diabetes mellitus. J Physiol Sci. 2012;62:469–78.PubMedCrossRef Skapare E, Konrade I, Liepinsh E, Makrecka M, Zvejniece L, Svalbe B, et al. Glyoxalase 1 and glyoxalase 2 activities in blood and neuronal tissue samples from experimental animal models of obesity and type 2 diabetes mellitus. J Physiol Sci. 2012;62:469–78.PubMedCrossRef
124.
go back to reference Eaton SE, Harris ND, Rajbhandari SM, Greenwood P, Wilkinson ID, Ward JD, et al. Spinal-cord involvement in diabetic peripheral neuropathy. Lancet. 2001;7:35–6.CrossRef Eaton SE, Harris ND, Rajbhandari SM, Greenwood P, Wilkinson ID, Ward JD, et al. Spinal-cord involvement in diabetic peripheral neuropathy. Lancet. 2001;7:35–6.CrossRef
125.
go back to reference Selvarajah D, Wilkinson ID, Emery CJ, Harris ND, Shaw PJ, Witte DR, et al. Early involvement of the spinal cord in diabetic peripheral neuropathy. Diabetes Care. 2006;29:2664–9.PubMedCrossRef Selvarajah D, Wilkinson ID, Emery CJ, Harris ND, Shaw PJ, Witte DR, et al. Early involvement of the spinal cord in diabetic peripheral neuropathy. Diabetes Care. 2006;29:2664–9.PubMedCrossRef
126.
go back to reference Selvarajah D, Wilkinson ID, Emery CJ, Shaw PJ, Griffiths PD, Gandhi R, et al. Thalamic neuronal dysfunction and chronic sensorimotor distal symmetrical polyneuropathy in patients with type 1 diabetes mellitus. Diabetologia. 2008;51:2088–92.PubMedCrossRef Selvarajah D, Wilkinson ID, Emery CJ, Shaw PJ, Griffiths PD, Gandhi R, et al. Thalamic neuronal dysfunction and chronic sensorimotor distal symmetrical polyneuropathy in patients with type 1 diabetes mellitus. Diabetologia. 2008;51:2088–92.PubMedCrossRef
127.
go back to reference Sorensen L, Siddall PJ, Trenell MI, Yue DK. Differences in metabolites in pain-processing brain regions in patients with diabetes and painful neuropathy. Diabetes Care. 2008;31:980–1.PubMedCrossRef Sorensen L, Siddall PJ, Trenell MI, Yue DK. Differences in metabolites in pain-processing brain regions in patients with diabetes and painful neuropathy. Diabetes Care. 2008;31:980–1.PubMedCrossRef
128.
go back to reference Selvarajah D, Wilkinson ID, Gandhi R, Griffiths PD, Tesfaye S. Microvascular perfusion abnormalities of the Thalamus in painful but not painless diabetic polyneuropathy: a clue to the pathogenesis of pain in type 1 diabetes. Diabetes Care. 2011;34:718–20.PubMedCrossRef Selvarajah D, Wilkinson ID, Gandhi R, Griffiths PD, Tesfaye S. Microvascular perfusion abnormalities of the Thalamus in painful but not painless diabetic polyneuropathy: a clue to the pathogenesis of pain in type 1 diabetes. Diabetes Care. 2011;34:718–20.PubMedCrossRef
129.
go back to reference Cauda F, Sacco K, Duca S, Cocito D, D’Agata F, Geminiani GC, et al. Altered resting state in diabetic neuropathic pain. PLoS One. 2009;4:e4542.PubMedCrossRef Cauda F, Sacco K, Duca S, Cocito D, D’Agata F, Geminiani GC, et al. Altered resting state in diabetic neuropathic pain. PLoS One. 2009;4:e4542.PubMedCrossRef
130.
go back to reference • Selvarajah D, Wilkinson ID, Davies J, Gandhi R, Tesfaye S. Central nervous system involvement in diabetic neuropathy. Curr Diab Rep. 2011;11:310–22. This paper reviews the findings on central mechanisms of neuropathic pain in diabetes. • Selvarajah D, Wilkinson ID, Davies J, Gandhi R, Tesfaye S. Central nervous system involvement in diabetic neuropathy. Curr Diab Rep. 2011;11:310–22. This paper reviews the findings on central mechanisms of neuropathic pain in diabetes.
131.
go back to reference Fischer TZ, Tan AM, Waxman SG. Thalamic neuron hyperexcitability and enlarged receptive fields in the STZ model of diabetic pain. Brain Res. 2009;1268:154–61.PubMedCrossRef Fischer TZ, Tan AM, Waxman SG. Thalamic neuron hyperexcitability and enlarged receptive fields in the STZ model of diabetic pain. Brain Res. 2009;1268:154–61.PubMedCrossRef
132.
go back to reference • Fischer TZ, Waxman SG. Neuropathic pain in diabetes-evidence for a central mechanism. Nat Rev Neurol. 2010;6:462–6. This paper reviews the findings that suggest that thalamic neurons can act as central generators or amplifiers of pain in diabetes.PubMedCrossRef • Fischer TZ, Waxman SG. Neuropathic pain in diabetes-evidence for a central mechanism. Nat Rev Neurol. 2010;6:462–6. This paper reviews the findings that suggest that thalamic neurons can act as central generators or amplifiers of pain in diabetes.PubMedCrossRef
133.
go back to reference Goldberg YP, Pimstone SN, Namdari R, Price N, Cohen C, Sherrington RP, et al. Human Mendelian pain disorders: a key to discovery and validation of novel analgesics. Clin Genet. 2012;82:367–73.PubMedCrossRef Goldberg YP, Pimstone SN, Namdari R, Price N, Cohen C, Sherrington RP, et al. Human Mendelian pain disorders: a key to discovery and validation of novel analgesics. Clin Genet. 2012;82:367–73.PubMedCrossRef
134.
go back to reference Faber CG, Hoeijmakers JG, Ahn HS, Cheng X, Han C, Choi JS, et al. Gain of function Naν1.7 mutations in idiopathic small fiber neuropathy. Ann Neurol. 2012;71:26–39.PubMedCrossRef Faber CG, Hoeijmakers JG, Ahn HS, Cheng X, Han C, Choi JS, et al. Gain of function Naν1.7 mutations in idiopathic small fiber neuropathy. Ann Neurol. 2012;71:26–39.PubMedCrossRef
135.
go back to reference Faber CG, Lauria G, Merkies IS, Cheng X, Han C, Ahn HS, et al. Gain-of-function Nav1.8 mutations in painful neuropathy. Proc Natl Acad Sci U S A. 2012;109:19444–9.PubMedCrossRef Faber CG, Lauria G, Merkies IS, Cheng X, Han C, Ahn HS, et al. Gain-of-function Nav1.8 mutations in painful neuropathy. Proc Natl Acad Sci U S A. 2012;109:19444–9.PubMedCrossRef
136.
go back to reference Tegeder I, Scheving R, Wittig I, Geisslinger G. SNO-ing at the nociceptive synapse? Pharmacol Rev. 2011;63:366–89.PubMedCrossRef Tegeder I, Scheving R, Wittig I, Geisslinger G. SNO-ing at the nociceptive synapse? Pharmacol Rev. 2011;63:366–89.PubMedCrossRef
137.
go back to reference Tegeder I, Costigan M, Griffin RS, Abele A, Belfer I, Schmidt H, et al. GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence. Nat Med. 2006;12:1269–77.PubMedCrossRef Tegeder I, Costigan M, Griffin RS, Abele A, Belfer I, Schmidt H, et al. GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence. Nat Med. 2006;12:1269–77.PubMedCrossRef
138.
go back to reference Backonja M, Woolf CJ. Future directions in neuropathic pain therapy: closing the translational loop. Oncologist. 2010;2:24–9.CrossRef Backonja M, Woolf CJ. Future directions in neuropathic pain therapy: closing the translational loop. Oncologist. 2010;2:24–9.CrossRef
139.
go back to reference Hotta N, Yasuda K, Sumita Y, Sano T, Kakuta H, Nagashima M, et al. Effects of a novel aldose reductase inhibitor, fidarestat (SNK-860), on vibration perception threshold and subjective symptoms in patients with diabetic polyneuropathy: an open-label pilot study. Clin Drug Investig. 2004;24:671–80. Hotta N, Yasuda K, Sumita Y, Sano T, Kakuta H, Nagashima M, et al. Effects of a novel aldose reductase inhibitor, fidarestat (SNK-860), on vibration perception threshold and subjective symptoms in patients with diabetic polyneuropathy: an open-label pilot study. Clin Drug Investig. 2004;24:671–80.
140.
go back to reference Sima AA, Calvani M, Mehra M, Amato A. Acetyl-L-Carnitine Study Group. Acetyl-L-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy: an analysis of 2 randomized placebo-controlled trials. Diabetes Care. 2005;28:89–94.PubMedCrossRef Sima AA, Calvani M, Mehra M, Amato A. Acetyl-L-Carnitine Study Group. Acetyl-L-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy: an analysis of 2 randomized placebo-controlled trials. Diabetes Care. 2005;28:89–94.PubMedCrossRef
141.
go back to reference Ziegler D, Movsesyan L, Mankovsky B, Gurieva I, Abylaiuly Z, Strokov I. Treatment of symptomatic polyneuropathy with actovegin in type 2 diabetic patients. Diabetes Care. 2009;32:1479–84.PubMedCrossRef Ziegler D, Movsesyan L, Mankovsky B, Gurieva I, Abylaiuly Z, Strokov I. Treatment of symptomatic polyneuropathy with actovegin in type 2 diabetic patients. Diabetes Care. 2009;32:1479–84.PubMedCrossRef
142.
go back to reference Ropper AH, Gorson KC, Gooch CL, Weinberg DH, Pieczek A, Ware JH, et al. Vascular endothelial growth factor gene transfer for diabetic polyneuropathy: a randomized, double-blinded trial. Ann Neurol. 2009;65:386–93.PubMedCrossRef Ropper AH, Gorson KC, Gooch CL, Weinberg DH, Pieczek A, Ware JH, et al. Vascular endothelial growth factor gene transfer for diabetic polyneuropathy: a randomized, double-blinded trial. Ann Neurol. 2009;65:386–93.PubMedCrossRef
143.
go back to reference Ziegler D, Nowak H, Kempler P, Vargha P, Low PA. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabet Med. 2004;21:114–21.PubMedCrossRef Ziegler D, Nowak H, Kempler P, Vargha P, Low PA. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabet Med. 2004;21:114–21.PubMedCrossRef
144.
go back to reference Ziegler D, Ametov A, Barinov A, Dyck PJ, Gurieva I, Low PA, et al. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care. 2006;29:2365–70.PubMedCrossRef Ziegler D, Ametov A, Barinov A, Dyck PJ, Gurieva I, Low PA, et al. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care. 2006;29:2365–70.PubMedCrossRef
145.
go back to reference Fonseca VA, Lavery LA, Thethi TK, Daoud Y, DeSouza C, Ovalle F, et al. Metanx in type 2 diabetes with peripheral neuropathy: a randomized trial. Am J Med. 2013;126:141–9.PubMedCrossRef Fonseca VA, Lavery LA, Thethi TK, Daoud Y, DeSouza C, Ovalle F, et al. Metanx in type 2 diabetes with peripheral neuropathy: a randomized trial. Am J Med. 2013;126:141–9.PubMedCrossRef
146.
go back to reference Chan AW, MacFarlane IA, Bowsher D, Wells JC, Bessex C, Griffiths K. Chronic pain in patients with diabetes mellitus: comparison with a non-diabetic population. The Pain Clinic. 1990;3:147–59. Chan AW, MacFarlane IA, Bowsher D, Wells JC, Bessex C, Griffiths K. Chronic pain in patients with diabetes mellitus: comparison with a non-diabetic population. The Pain Clinic. 1990;3:147–59.
Metadata
Title
Painful and Painless Diabetic Neuropathy: One Disease or Two?
Authors
Vincenza Spallone
Carla Greco
Publication date
01-08-2013
Publisher
Springer US
Published in
Current Diabetes Reports / Issue 4/2013
Print ISSN: 1534-4827
Electronic ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-013-0387-7

Other articles of this Issue 4/2013

Current Diabetes Reports 4/2013 Go to the issue

Microvascular Complications-Neuropathy (D Ziegler, Section Editor)

Neurovascular Function and Sudorimetry in Health and Disease

Microvascular Complications-Nephropathy (B Roshan, Section Editor)

Emerging Roles for miRNAs in the Development, Diagnosis, and Treatment of Diabetic Nephropathy

Microvascular Complications-Nephropathy (B Roshan, Section Editor)

Novel Biomarkers for the Progression of Diabetic Nephropathy: Soluble TNF Receptors

Microvascular Complications-Retinopathy (JK Sun, Section Editor)

Current State of Care for Diabetic Retinopathy in India

Microvascular Complications-Retinopathy (JK Sun, Section Editor)

Imaging of the Parafoveal Capillary Network in Diabetes

Microvascular Complications-Neuropathy (D Ziegler, Section Editor)

Corneal Confocal Microscopy: A New Technique for Early Detection of Diabetic Neuropathy

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.